ArticleNature communications2022

Covalent narlaprevir- and boceprevir-derived hybrid inhibitors of SARS-CoV-2 main protease.

Daniel W Kneller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.